In comparison to the alterations in cathepsin-D and PCNA, which are not highly correlated to IDC-NOS, almost 50% of tumors classified as MBCs in our study were characterized by the positive expression of these two genes. The gene discussed is PCNA; the disease is maternal uniparental disomy of chromosome 20.